Keyword Connections

amyloid-β

Journals

2

1 European journal of nuclear medicine and molecular imaging

2 neurobiology of aging

Research Groups

0

No Research Group Connected

Bibliographies

25

1 Quercetin reduces eIF2α phosphorylation by GADD34 induction.

2 removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report

3 alzheimer’s transgenic model is characterized by very early brain network alterations and β-ctf fragment accumulation: reversal by β-secretase inhibition

4 monoacylated cellular prion proteins reduce amyloid-β-induced activation of cytoplasmic phospholipase a2 and synapse damage

5 mirna-431 prevents amyloid-β-induced synapse loss in neuronal cell culture model of alzheimer's disease by silencing kremen1

6 impaired memory and evidence of histopathology in ca1 pyramidal neurons through injection of aβ1-42 peptides into the frontal cortices of rat

7 transplantation of human menstrual blood-derived mesenchymal stem cells alleviates alzheimer’s disease-like pathology in app/ps1 transgenic mice

8 Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.

9 Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.

10 Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage

11 [The plasma level of amyloid-β is associated with cognitive decline: a two years follow-up study in Xi'an rural areas].

12 A new purified Lawsoniaside remodels amyloid-β fibrillation into a less toxic and non-amyloidogenic pathway.

13 Mercury and Alzheimer's Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization.

14 Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.

15 Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease

16 oligomeric amyloid-β peptide on sialylic lewisx–selectin bonding at cerebral endothelial surface

17 the physiological roles of amyloid-β peptide hint at new ways to treat alzheimer's disease

18 insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-β aggregation inhibitors

19 insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes

20 breaking the code of amyloid-β oligomers

21 alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of ppars.

22 Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

23 Longitudinal head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

24 The image quality, amyloid-β detectability, and acquisition time of clinical florbetapir positron emission tomography in Alzheimer’s disease and healthy adults

25 Amyloid-β deposition in basal frontotemporal cortex is associated with selective disruption of temporal mnemonic discrimination.